Intact Investment Management Inc.
Source: SEC Form 13F · as of Mar 2026Intact Investment Management Inc. holds 19 biotech & pharma companies tracked by BioSniper, totaling $151.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$151.6M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 107,630 | $23.4M |
| PMPhilip Morris International Inc | 140,700 | $23.3M |
| MRKMerck & Co., Inc. | 173,500 | $20.9M |
| PFEPFIZER INC | 615,500 | $17.3M |
| JNJJOHNSON & JOHNSON | 54,729 | $13.4M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 43,900 | $11.9M |
| ABTABBOTT LABORATORIES | 93,400 | $9.6M |
| GILDGILEAD SCIENCES, INC. | 50,600 | $7.1M |
| BMYBRISTOL MYERS SQUIBB CO | 104,700 | $6.4M |
| AMGNAMGEN INC | 15,300 | $5.4M |
| GMOptec International, Inc. | 42,600 | $3.2M |
| LLYELI LILLY & Co | 3,180 | $2.9M |
| REGNREGENERON PHARMACEUTICALS, INC. | 3,010 | $2.3M |
| ELVElevance Health Inc. | 3,370 | $987K |
| BHCBausch Health Companies Inc. | 175,100 | $946K |
| GMEDGlobus Medical Inc. | 8,600 | $741K |
| CAHCardinal Health Inc. | 3,200 | $676K |
| ZTSZoetis Inc. | 5,700 | $674K |
| IQVIQVIA Holdings Inc. | 3,800 | $648K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.